Sho Saeki

1.6k total citations
94 papers, 913 citations indexed

About

Sho Saeki is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Sho Saeki has authored 94 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 49 papers in Oncology and 17 papers in Surgery. Recurrent topics in Sho Saeki's work include Lung Cancer Treatments and Mutations (33 papers), Lung Cancer Research Studies (22 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (21 papers). Sho Saeki is often cited by papers focused on Lung Cancer Treatments and Mutations (33 papers), Lung Cancer Research Studies (22 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (21 papers). Sho Saeki collaborates with scholars based in Japan, United States and United Kingdom. Sho Saeki's co-authors include Yusuke Tomita, Shinya Sakata, Takuro Sakagami, Koichi Saruwatari, Ryo Sato, Takayuki Jodai, Kimitaka Akaike, Shinji Iyama, Tokunori Ikeda and Shiho Ishizuka and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sho Saeki

83 papers receiving 902 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sho Saeki Japan	15	435	427	253	111	104	94	913
Wen‐Kuan Huang Taiwan	18	281 0.6×	226 0.5×	169 0.7×	144 1.3×	111 1.1×	82	905
Marthe S. Paats Netherlands	16	237 0.5×	467 1.1×	143 0.6×	44 0.4×	166 1.6×	47	762
Luigina Graziosi Italy	16	348 0.8×	356 0.8×	205 0.8×	457 4.1×	103 1.0×	74	1.0k
Jen‐Seng Huang Taiwan	16	276 0.6×	131 0.3×	92 0.4×	93 0.8×	84 0.8×	40	632
Yuki Yoshimatsu Japan	15	219 0.5×	361 0.8×	346 1.4×	155 1.4×	168 1.6×	104	902
J.M. Tourani France	15	481 1.1×	183 0.4×	152 0.6×	80 0.7×	94 0.9×	34	807
Ronan Desmond United States	13	206 0.5×	113 0.3×	129 0.5×	104 0.9×	59 0.6×	30	1.4k
Shin Akagawa Japan	10	301 0.7×	407 1.0×	157 0.6×	577 5.2×	223 2.1×	28	1.1k
Masao Ichiki Japan	15	369 0.8×	273 0.6×	196 0.8×	66 0.6×	112 1.1×	47	622
Nahla Azzam Saudi Arabia	16	205 0.5×	153 0.4×	152 0.6×	239 2.2×	122 1.2×	73	688

Countries citing papers authored by Sho Saeki

Since Specialization

Citations

This map shows the geographic impact of Sho Saeki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Saeki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Saeki more than expected).

Fields of papers citing papers by Sho Saeki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Saeki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Saeki. The network helps show where Sho Saeki may publish in the future.

Co-authorship network of co-authors of Sho Saeki

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Saeki. A scholar is included among the top collaborators of Sho Saeki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Saeki. Sho Saeki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saruwatari, Koichi, Kosuke Fujino, Takayuki Jodai, et al.. (2024). Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation. Journal of Thoracic Disease. 16(2). 1151–1160.

Sakakibara‐Konishi, Jun, Takayasu Kurata, Kageaki Watanabe, et al.. (2023). 1482P Multicenter pharmacokinetic study of pembrolizumab for non-small cell lung cancer in elderly adults aged over 75 years. Annals of Oncology. 34. S838–S838. 1 indexed citations

Sato, Ryo, Takashi Semba, Yusuke Tomita, et al.. (2021). TGFβ Signaling Activated by Cancer-Associated Fibroblasts Determines the Histological Signature of Lung Adenocarcinoma. Cancer Research. 81(18). 4751–4765. 42 indexed citations

Takemura, Tamiko, Hidenori Ichiyasu, Sho Saeki, et al.. (2021). Pathological and clinical relevance of selective recruitment of Langerhans cells in the respiratory bronchioles of smokers. Respiratory Investigation. 59(4). 513–521. 3 indexed citations

Ishii, Yasutaka, Masahiro Serikawa, T. Tsuboi, et al.. (2021). The role of apparent diffusion coefficient value in the diagnosis of localized type 1 autoimmune pancreatitis: differentiation from pancreatic ductal adenocarcinoma and evaluation of response to steroids. Abdominal Radiology. 46(5). 2014–2024. 7 indexed citations

Sakata, Shinya, Shinji Iyama, Kentaro Tokunaga, et al.. (2021). Airway Pseudomonas aeruginosa density in mechanically ventilated patients: clinical impact and relation to therapeutic efficacy of antibiotics. Critical Care. 25(1). 59–59. 7 indexed citations

Tomita, Yusuke, Tokunori Ikeda, Shinya Sakata, et al.. (2020). Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer. Cancer Immunology Research. 8(10). 1236–1242. 161 indexed citations

Akaike, Kimitaka, Hajime Iwagoe, Hiroshi Takahashi, et al.. (2020). Decrease in hemoglobin level predicts increased risk for severe respiratory failure in COVID-19 patients with pneumonia. Respiratory Investigation. 59(2). 187–193. 32 indexed citations

Takayama, Koichi, Junji Uchino, Masaki Fujita, et al.. (2019). Phase I/II Study of Docetaxel and S-1 in Previously-Treated Patients with Advanced Non-Small Cell Lung Cancer: LOGIK0408. Journal of Clinical Medicine. 8(12). 2196–2196. 1 indexed citations

10.

Sakata, Shinya, Kazuyoshi Nakamura, Hiroko Okabayashi, et al.. (2019). Acute Exacerbation of Idiopathic Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma after Transcatheter Arterial Therapy Using Miriplatin. Internal Medicine. 58(9). 1329–1333.

11.

Yamazaki, Ryo, Osamu Nishiyama, Sho Saeki, et al.. (2019). The utility of the Japanese Association for Acute Medicine DIC scoring system for predicting survival in acute exacerbation of fibrosing idiopathic interstitial pneumonia. PLoS ONE. 14(8). e0212810–e0212810. 6 indexed citations

12.

Ichiyasu, Hidenori, Susumu Hirosako, Sho Saeki, et al.. (2019). Four-meter gait speed predicts daily physical activity in patients with chronic respiratory diseases. Respiratory Investigation. 57(4). 368–375. 7 indexed citations

13.

Sakata, Shinya, et al.. (2018). Reversible Restrictive Lung Disease in Pseudomesotheliomatous Carcinoma in a Lung Harboring a <i>HER2</i>-mutation. Internal Medicine. 57(15). 2223–2226. 2 indexed citations

14.

Kashiwabara, Kosuke, Yusuke Tomita, Sho Saeki, et al.. (2018). Lung abscess following bronchoscopy due to multidrug-resistant Capnocytophaga sputigena adjacent to lung cancer with high PD-L1 expression. Journal of Infection and Chemotherapy. 24(10). 852–855. 10 indexed citations

15.

Sakata, Shinya, Sho Saeki, Yoshihiko Sakata, et al.. (2018). The impact of continuing ALK inhibitors beyond initial disease progression on clinical outcome in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter retrospective analysis. Annals of Oncology. 29. ix163–ix163. 1 indexed citations

16.

Hirosako, Susumu, Kazuyoshi Nakamura, Shohei Hamada, et al.. (2018). Respiratory evaluation of the risk for postoperative pulmonary complications in patients who preoperatively consulted pulmonologists: Studying both patients who underwent and who precluded planned surgery. Respiratory Investigation. 56(6). 448–456. 3 indexed citations

17.

Nakamura, Atsushi, Hibiki Udagawa, Shingo Matsumoto, et al.. (2017). Prevalence of NTRK gene fusions in a large cohort of Japanese patients with lung cancer. Annals of Oncology. 28. x126–x126. 3 indexed citations

18.

Sakata, Shinya, Sho Saeki, Ryo Sato, et al.. (2017). Long-term complete response to carboplatin plus paclitaxel combined with bevacizumab in a patient with metastatic spindle cell carcinoma. Respiratory Investigation. 55(6). 372–375. 5 indexed citations

19.

Matsumoto, Shingo, Kiyotaka Yoh, Kadoaki Ohashi, et al.. (2016). Detectability of druggable gene fusions by amplicon-based next generation sequencing in nationwide lung cancer genomic screening project (LC-SCRUM-Japan). Annals of Oncology. 27. vi420–vi420.

20.

Hotta, Katsuyuki, Jiichiro Sasaki, Sho Saeki, et al.. (2015). Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non–Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol. Clinical Lung Cancer. 17(1). 75–79. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact